Intellectual Property & Legal service

Regulatory strategy and early health technology assessment

Provided by European Infrastructure for Translational Medicine (EATRIS) · Netherlands

Service description

Covering pharmaceutical, ATMP, MDR legislation EATRIS provides regulatory support for most types of medical product. Our range of services include:  Expert opinion, Orphan Drug Designation and Scientific Advice application at the EMA;Pre-clinical and clinical plan development, Informal scientific advice with national competent authorities for highly complex projects, Access to EATRIS Regulatory Database (free of charge) that contains information about the regulatory requirements, guidelines and legislations from 27 EU countries (as well as Norway, Switzerland, Turkey and Israel) regarding drug and medical device development derived from the application of European legislation.

We work with a braod network of experts across Europe, availability of specific competences cannot be guaranteed at all times.

← Back to Intellectual Property & Legal services